A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer

Gynecologic Oncology

Volumn 69, Issue 2, 1998, Pages 137-145

  Thomas, G ^a   Dembo, A ^a   Ackerman, I ^a   Franssen, E ^a   Balogh, J ^a   Fyles, A ^b   Levin, W ^b  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ADULT; ARTICLE; BEAM THERAPY; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX CANCER;

EID: 0032077980     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.4990     Document Type: Article

References (34)

1. Coia L, Won M, Lanciano R, Marcial A, Martz K. The patterns of care outcome study for cancer of the uterine cervix. Cancer. 66:1990;2451-2456.
2. Horiot J-C, Pigneux J, Pourquier H, Schraub S, Achille E, Keiling R, Combes P, Rozan R, Vrousos C, Daly N. Radiotherapy alone in carcinoma of the intact uterine cervix according to G.H. Fletcher Guidelines: A French Cooperative Study of 1383 cases. Int J Radiat Oncol Biol Phys. 14:1988;605-611.
3. Perez C A. Radiation therapy in the management of cancer of the cervix. Part II. Oncology. 7:1993;61-76.
4. Perez C A, Breaux S, Bedwiniek J, Madoc-Jones H, Carmel M, Purdy J, Walz B J. Radiation therapy alone in the treatment of carcinoma of the cervix. II. Analysis of complications. Cancer. 54:1984;235-246.
5. Haie C, Pejovic M H, Gerbaulet A, Horiot J C, Pourquier H, Delouche J, Heinz J F, Brune D, Fenton J, Pizzi G, Bey P, Brossel R, Pillement P, Volterrani F, Chassagne D. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. Radiother Oncol. 11:1988;101-112.
6. Rotman M, Choi K, Guze C, Marcial V, Hornback N, John M. Prophylactic irradiation of the paraaortic lymph node chain in stage IIB and bulky stage IB carcinoma of the cervix, initial treatment results of RTOG 7920. Int J Radiat Oncol Biol Phys. 19:1990;513-521.
7. Varghese C, Rangad F, Jose C C, Raveendran P, Subhashini J, Ramadas K, Idicula J, Pais A, Roul R K. Hyperfractionation in advanced carcinoma of the uterine cervix: A preliminary report. Int J Radiat Oncol Biol Phys. 23:1992;393-396.
8. Fletcher G H, Lindberg R D, Caderao J B, Taylor Wharton J. Hyperbaric oxygen as a radiotherapeutic adjuvant in advanced cancer of the uterine cervix. Cancer. 39:1977;617-623.
9. Ward A J, Dixon B. Carcinoma of the cervix: Results of a hyperbaric oxygen trial associated with the use of the cathetron. Br J Radiol. 30:1979;383-387.
10. Stehman F B, Bundy B N, Thomas G, Keys H M, d'Ablaing G II, Fowler W C Jr, Mortel R, Creasman W T. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: Long term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol. 11:1993;1523-1528.
11. Dische S. Hyperbaric oxygen: The Medical Research Council trials and their clinical significance. Br J Radiol. 51:1978;888-894.
12. Souhami L, Gil R A, Allan S E, Canary P CV, Araujo C MM, Pinto L HJ, Silveira T RP. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol. 9:1991;970-977.
13. Tattersall M HN, Ramirez C, Coppleson M. A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer. Int J Gynecol Cancer. 2:1992;244-251.
14. Tattersall M HN, Lorvidhaya V, Vootiprux V, Cheirsilpa A, Wong F, Azhar T, Lee H P, Kang S B, Yen M-S, Kampono N, Aziz F. A randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J Clin Oncol. 13:1995;444-451.
15. Sardi J, Giaroli A, Sananes C, Rueda N G, Vighi S, Ferreira M, Bastardas M, Paniceres G, di Paola G. Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma cervix uteri: An unexpected therapeutic management. Int Gynecol Cancer. 6:1996;85-93.
16. Kumar L, Kaushal R, Nandy M, Biswal B M, Kumar S, Kriplani A, Singh R, Rath G K. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer. A randomized study. Gynecol Oncol. 54:1994;307-315.
17. Chauvergne J, Lhommé C, Rohart J, Héron J F, Ayme Y, Goupil A, Fargeot P, David M. Chimiothérapie néoadjuvante des cancers du col utérin aux stades IIB et III. Résultats éloignes d'un essai randomisé pluricentrique portant sur 151 patients. Bull Cancer. 80:1993;1069-1079.
18. Steel G G, Peckham M J. Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity. Int J Radiat Oncol Biol Phys. 5:1979;85-91.
19. Piver M S, Barlow J J, Vongtama V, Blumenson L. Hydroxyurea: A radiation potentiator in carcinoma of the uterine cervix. A randomized double-blind study. Am J Obst Gynecol. 147:1983;803-808.
20. Cummings B J, Rider W D, Harwood A R, Keane T J, Thomas G M, Erlichman C, Fine S. Combined radical radiation therapy and chemotherapy for primary squamous cell carcinoma of the anal canal. Cancer Treat Rep. 66:1982;489-492.
21. Nigro N D, Vaitkevicius V K, Considine B. Combined therapy for cancer of the anal canal. Dis Colon Rectum. 17:1974;354-356.
22. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicus V, Cooper J, Byhardt R, Davis L, Emami B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 326:1992;1593-1597.
23. Byfield J E, Calabro-Jones P, Klisar I, Kulhanian F. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil of F torafur and x-rays. Int J Radiat Oncol Biol Phys. 59:1982;2422-2427.
24. Nakajima Y, Miyamoto T, Tanabe M, Watanabe I, Terasima T. Enhancement of mammalian cell killing by 5-fluorouracil in combination with x-rays. Cancer Res. 39:1979;3763-3767.
25. Thomas G M, Dembo A J, Beale F, Bean H, Bush R, Herman J, Pringle J, Rawlings G, Sturgeon J, Fine S, Black B E. Concurrent radiation, Mitomycin C and 5-Fluorouracil in poor prognosis carcinoma of the cervix. Preliminary results of Phase I/II study. Int J Radiat Oncol Biol Phys. 10:1984;1785-1789.
26. Thomas, G, M.
27. Withers H, Peters L, Kogelnik H. The Pathobiology of Late Effects of Irradiation. Radiation Biology in Cancer Research. 1980;Raven Press, New York. p. 439-448.
28. Eifel P J, Levenback C, Oswald M J. The time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 30:1994;212.
29. Thomas G M, Dembo A J, Fyles A, Gadalla T, Beale F, Bean H, Pringle J, Rawlings G, Bush R, Black B. Concurrent chemoradiation in advanced cervical cancer. Gynecol Oncol. 38:1990;446-451.
30. Lanciano R M, Pajak T F, Martz K, Hanks G E. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study. Int J Radiat Oncol Biol Phys. 25:1993;391-397.
31. Perez C A, Grigsby P W, Nene S M, Camel H M, Galakatos A, Kao M-S, Lockett M A. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer. 69:1992;2796-2806.
32. Fuks Z, Leibel S A, Wallner K E, Begg C B, Fair W R, Anderseon L L, Hilaris B S, Whitmore W R. The effect of local control on metastatic dissemination in carcinoma of the prostate: Long-term results in patients treatment with 125-I implantation. Int J Radiat Oncol Biol Phys. 21:1991;537-547.
33. Suit H D. Local control and patient survival. Int J Radiat Oncol Biol Phys. 23:1992;653-660.
34. Leibel S A, Fuks Z. Is local failure a cause of or a marker for metastatic dissemination in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 24:1992;377-380.